Hydrogenology
Hydrogenology editorial study record

Safety and efficacy of a novel fecal microbiota transplantation method using hydrogen nanobubble water without antibiotics or bowel cleansing in children with autism spectrum disorder: an open-label, single-arm study demonstrating improvements in core and comorbidity symptoms.

Shirotani M, Shimizu S, Kitamura K, Mikawa Y, Haruna R, Kawai Y, Koide S, Mohri I, Matsuzaki H, Tsuchiya KJ, Tanaka Y, Katayama T. · Frontiers in Pediatrics. 2026;14:1767346.

HumanOther formsPublished 2026
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Prospective open-label single-arm study

Research topic

Other neurological conditions

Administration classification

Other forms

Study result signal

Positive for the combined procedure; indeterminate for molecular hydrogen.

Outcome type

Clinical symptom scales and microbiome outcomes for a combined intervention.

Reported in the source

Methods at a glance

Population or model

Children with autism spectrum disorder receiving fecal microbiota transplantation.

Sample

30 children enrolled in the single study arm.

Duration

30-week study period.

Intervention

Fecal microbiota transplantation prepared with hydrogen nanobubble water, without antibiotic pretreatment or bowel cleansing.

Hydrogen form

Hydrogen nanobubble water used as the FMT preparation vehicle; not Brown's gas.

H₂ specification

Approximately 100 g donor stool was mixed with 250 g hydrogen nanobubble water; a separately quantified administered H2 dose was not reported.

H₂ flow

Not applicable — FMT preparation.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

No concurrent control and no FMT-without-hydrogen comparator.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Autism-related symptom scales, comorbidity measures, adverse events and microbiome measures.

Reported result

Several symptom scores improved over time and the article reports no serious safety signal attributed to the procedure.

Results-extraction completeness

The full article, registration, protocol, results and adverse-event reporting were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Open-label, uncontrolled and inseparable from FMT. Changes cannot be attributed specifically to hydrogen nanobubble water.

Applies directly to

The combined FMT procedure studied; not hydrogen as a standalone intervention.

Preliminary appraisal framework

ROBINS-I — preliminary

Preliminary risk-of-bias status

Serious concerns

Appraisal rationale

Critical confounding and expectation/time effects, with no control capable of isolating hydrogen.

Appraisal domains

Non-random selection or allocation · Confounding and co-intervention concerns · Attrition/reporting checked where stated · Some outcomes are subjective or laboratory-only · No outcome-level protocol comparison completed

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 41890300 · DOI: 10.3389/fped.2026.1767346

Publisher access

Free full article in PubMed Central.

Extraction basis

PubMed record and PubMed Central full text; extraction checked 9 August 2026.

Record revision

2026-08-10